Загрузка...
Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic lung disease with no clear etiology and a paucity of therapeutic options. Nintedanib (previously known as BIBF 1120) is a tyrosine kinase receptor antagonist which inhibits a number of key receptors, including those for platelet...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3693725/ https://ncbi.nlm.nih.gov/pubmed/23818761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S38833 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|